timolol
Showing 1 - 25 of 321
Patients Who Received EGFR-TKI for the Treatment of NSCLC and Developed Paronychia (Affecting Fingernails, Toenails or Both)
Recruiting
- Patients Who Received EGFR-TKI for the Treatment of Non-small Cell Lung Cancer and Developed Paronychia (Affecting Fingernails, Toenails or Both)
- Topical Timolol
-
Hong Kong, Hong KongQueen Mary Hospital
Nov 14, 2023
Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Dorzolamide / Timolol Ophthalmic Solution
- dorzolamide/timolol
-
Olivos, Buenos Aires, Argentina
- +5 more
May 10, 2023
Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System
Recruiting
- Cataract
- +2 more
- Bimatoprost Implant System (High Dose)
- +4 more
-
Glendale, ArizonaArizona Advanced Eye Research Institute
Nov 8, 2023
Acne Scars - Mixed Atrophic and Hypertrophic Trial (microneedling, microneedling with topical timolol 0.5%)
Not yet recruiting
- Acne Scars - Mixed Atrophic and Hypertrophic
- microneedling
- microneedling with topical timolol 0.5%
- (no location specified)
Oct 25, 2022
Open-Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Nebivolol Ophthalmic Suspension 1 Percent, Nebivolol Ophthalmic
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- Nebivolol Ophthalmic Suspension 1 Percent
- +3 more
-
Newport Beach, CaliforniaSite 0012
Jul 18, 2022
Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /
Completed
- Ocular Surface Disease
- Primary Open Angle Glaucoma
- Tafluprost, timolol maleate
-
Taoyuan city, TaiwanChang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022
Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial
Not yet recruiting
- Primary Open Angle Glaucoma (POAG)
- +3 more
- Experimental: QLS-111 ophthalmic solution, (0.015%)
- +4 more
- (no location specified)
Aug 30, 2023
Paronychia, Epidermal Growth Factor Receptor Inhibitor Trial in Taipei (Timolol maleate 0.5% ophthalmic solution, Cryotherapy
Recruiting
- Paronychia
- Epidermal Growth Factor Receptor Inhibitor
- Timolol maleate 0.5% ophthalmic solution
- Cryotherapy with liquid nitrogen
-
Taipei, TaiwanTaipei Municipal Wan-Fang Hospital
Jun 7, 2022
Glaucoma, Primary Open Angle, Ocular Hypertension Trial in Newport Beach (Study Treatment 1 WB007, Study Treatment 2 WB007,
Active, not recruiting
- Glaucoma, Primary Open Angle
- Ocular Hypertension
- Study Treatment 1 WB007
- +3 more
-
Newport Beach, CaliforniaEye Research Foundation
Dec 30, 2022
Glaucoma, Ocular Hypertensive Trial in Seoul (BRIDIN-plus Eye drops, Combigan Eye drops)
Completed
- Glaucoma
- Ocular Hypertensive
- BRIDIN-plus Eye drops
- Combigan Eye drops
-
Seoul, Seongnam, Bundang-gu, Korea, Republic ofSeungsoo Rho
Oct 9, 2023
OAG - Open-Angle Glaucoma, OHT - Ocular Hypertension Trial (Netarsudil 0.02% QD, Timolol maleate 0.5% BID)
Withdrawn
- OAG - Open-Angle Glaucoma
- OHT - Ocular Hypertension
- Netarsudil 0.02% QD
- Timolol maleate 0.5% BID
- (no location specified)
Mar 17, 2022
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Albany (QLS-101, Timolol Maleate)
Completed
- Primary Open Angle Glaucoma
- Ocular Hypertension
- QLS-101
- Timolol Maleate
-
Albany, GeorgiaDixon Eye Care
May 3, 2022
Acne Vulgaris, Rosacea Trial in Baltimore (Timolol)
Completed
- Acne Vulgaris
- Rosacea
- Timolol
-
Baltimore, MarylandJohns Hopkins Dermatology Department
Nov 4, 2021
Wound Heal Trial in Metairie (Timolol 0.25% Ophthalmic Solution, Standard Wound Care)
Recruiting
- Wound Heal
- Timolol 0.25% Ophthalmic Solution
- Standard Wound Care
-
Metairie, LouisianaSkin Surgery Centre
Oct 29, 2021
Glaucoma Trial in Gainesville (timolol maleate and dorzolamide HCl)
Completed
- Glaucoma
- timolol maleate and dorzolamide hydrochloride
-
Gainesville, FloridaUniversity of Florida
Dec 1, 2021
Wound of Skin, Wound Heal, Surgical Wound Trial in Boston (0.25% timolol gel with full-thickness skin grafts, Vaseline dressing)
Terminated
- Wound of Skin
- +3 more
- 0.25% timolol gel with full-thickness skin grafts
- Vaseline dressing
-
Boston, MassachusettsMohs and Dermatologic Surgery Center, Brigham and Women's Hospit
Jan 10, 2022
Glaucoma, Open-Angle, Ocular Hypertension Trial in Milano, Pavia, Roma (tafluprost/timolol)
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
-
Milano, Italy
- +2 more
Mar 18, 2022
Telangiectasia, Hereditary Hemorrhagic, Osler Rendu Disease Trial in Bron (Timolol nasal spray, Placebo nasal spray)
Completed
- Telangiectasia, Hereditary Hemorrhagic
- Osler Rendu Disease
- Timolol nasal spray
- Placebo nasal spray
-
Bron, FranceHospices Civils de Lyon - Hôpital Femme Mère Enfant / Service de
Oct 14, 2021
Infantile Hemangioma Trial in United States (0.25% Timolol Maleate Gel Forming Solution, 0.5% Timolol Maleate Gel Forming
Completed
- Infantile Hemangioma
- 0.25% Timolol Maleate Gel Forming Solution
- 0.5% Timolol Maleate Gel Forming Solution
-
Chicago, Illinois
- +11 more
Jan 18, 2022
Glaucoma Open-Angle Primary, Ocular Hypertension Trial in Albany (H-1337 0.6%, H-1337 1.0%, H-1337 Placebo)
Not yet recruiting
- Glaucoma Open-Angle Primary
- Ocular Hypertension
- H-1337 0.6%
- +3 more
-
Albany, GeorgiaDixon Eye Care
Jun 12, 2023
Normal Tension Glaucoma Trial in Sioux Falls (QLS-101)
Completed
- Normal Tension Glaucoma
-
Sioux Falls, South DakotaVance Thompson Vision
Oct 7, 2022
Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Travoprost Ophthalmic Topical Cream low-dose, Travoprost
Not yet recruiting
- Open Angle Glaucoma
- Ocular Hypertension
- Travoprost Ophthalmic Topical Cream low-dose
- +4 more
-
Newport Beach, CaliforniaGlaukos Clinical Study Site
Nov 22, 2023
Diabetic Macular Edema Trial in Tehran (Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide,
Active, not recruiting
- Diabetic Macular Edema
- Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide
- Injections of 1.25 mg of intravitreal bevacizumab with artificial tears
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Oct 6, 2021
Hereditary Hemorrhagic Telangiectasia Trial in Saint Louis (Timolol Gel, Placebo Gel)
Completed
- Hereditary Hemorrhagic Telangiectasia
- Timolol Gel
- Placebo Gel
-
Saint Louis, MissouriWashington University
Jul 29, 2021
Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, STN1012600 ophthalmic solution
Recruiting
- Open Angle Glaucoma, Ocular Hypertension
- STN1012600 ophthalmic solution 0.002%
- STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%
-
Aichi, Japan
- +15 more
Aug 16, 2022